A Study to Evaluate YH003 in Subjects With Advanced Solid Tumors

NCT05017623 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: YH003

Sponsor

Eucure (Beijing) Biopharma Co., Ltd